Bio-Rad Launches SARS-CoV-2, Flu, RSV Run Controls for Multiplexed Respiratory PCR Assays
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, has announced the launch of its SARS-CoV-2, Flu, RSV Positive and Negative Run Controls. The products enable laboratories to evaluate day-to-day and lot-to-lot variation of their multiplexed molecular assay and to test for operator proficiency.
The SARS-CoV-2, Flu, RSV Positive Run Control is manufactured with whole organism SARS-CoV-2, Influenza A, Influenza B and RSV (A). The product is formulated in a synthetic matrix and contains human genomic DNA.
The SARS-CoV-2, Flu, RSV Negative Run Control is negative for SARS-CoV-2, Influenza A, Influenza B and RSV (A) and is formulated in a synthetic matrix and contains human genomic DNA.
Both products are part of Exact Diagnostics range of quality control products and are available in kits of 5 vials, have a 1.0 mL fill volume, and can be stored at -20°C or below.
Ordering details: COVFLU for the positive run control and COVFLUNEG for the negative run control.
The SARS-CoV-2, Flu, RSV Positive Run Control is manufactured with whole organism SARS-CoV-2, Influenza A, Influenza B and RSV (A). The product is formulated in a synthetic matrix and contains human genomic DNA.
The SARS-CoV-2, Flu, RSV Negative Run Control is negative for SARS-CoV-2, Influenza A, Influenza B and RSV (A) and is formulated in a synthetic matrix and contains human genomic DNA.
Both products are part of Exact Diagnostics range of quality control products and are available in kits of 5 vials, have a 1.0 mL fill volume, and can be stored at -20°C or below.
Ordering details: COVFLU for the positive run control and COVFLUNEG for the negative run control.
